Chickenpox clinical trials
The registry lists 152 studies for Chickenpox across more than 10 countries. 26 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-15.
Status
- Completed
- 89
- Status unknown
- 14
- Recruiting
- 14
- Active, not recruiting
- 10
- Not yet recruiting
- 9
- Terminated
- 6
Phase
- Phase 3
- 61
- Phase 4
- 30
- Phase 2
- 26
- Phase 1
- 16
Where
- United States
- 33
- China
- 30
- Germany
- 11
- Thailand
- 8
- Italy
- 7
- Poland
- 6
Who runs them
GlaxoSmithKline (30) · Merck Sharp & Dohme LLC (20) · Sinovac (Dalian) Vaccine Technology Co., Ltd. (17) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Sanofi Pasteur, a Sanofi Company (5) · Beijing Center for Disease Control and Prevention (3) · Changchun Keygen Biological Products Co., Ltd. (3) · Suzhou Abogen Biosciences Co., Ltd. (3)
Studies
Recruiting first, then most recently updated. Showing 50 of 152 — search for more.
- SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 YearsRecruitingNCT07415252Phase 34 countries
- Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled TrialNot yet recruitingNCT07818356Phase 41 country
- Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or AboveRecruitingNCT07817108Phase 31 country
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of AgeNot yet recruitingNCT07742644Phase 36 countries
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of AgeRecruitingNCT07406360Phase 31 country
- Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese ChildrenNot yet recruitingNCT07473427Phase 31 country
- A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of AgeRecruitingNCT06740630Phase 311 countries
- A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of AgeRecruitingNCT06693895Phase 38 countries
- A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of AgeRecruitingNCT06806137Phase 32 countries
- A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of AgeRecruitingNCT06855160Phase 37 countries
- A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 YearsRecruitingNCT07054099Phase 31 country
- Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and AboveNot yet recruitingNCT07481604Phase 21 country
- Second Dose of Varicella Vaccine in Healthy ChildrenRecruitingNCT07475000Phase 31 country
- Zoster Vaccine to Enhance Protection Against Zoster in Solid-organ TransplantationNot yet recruitingNCT07443709Phase 21 country
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT073589101 country
- A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy ParticipantsNot yet recruitingNCT07205796Phase 2
- Evaluation of the Anti-VZV Vaccine Response of Patients With Immune-mediated Systemic Inflammatory Diseases Vaccinated in the Care SettingRecruitingNCT070470531 country
- Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP VaccineNot yet recruitingNCT06891872Phase 41 country
- An Immunity Persistence Study of Live Attenuated Varicella VaccineEnrolling by invitationNCT05095701Phase 41 country
- Correlation of Protection Against Varicella in an Exploratory StudyNot yet recruitingNCT06482216
- An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella VaccineEnrolling by invitationNCT06484686Phase 41 country
- A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult SubjectsyRecruitingNCT06068608Phase 11 country
- Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years OldEnrolling by invitationNCT05015686Phase 31 country
- Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella VaccinationRecruitingNCT05422508Phase 21 country
- Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated VaccinesNot yet recruitingNCT05952505Phase 41 country
- Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation RecipientsRecruitingNCT00492739Phase 2/31 country
- Herpes Virus Infections in Kidney Transplant PatientsActive, not recruitingNCT056049111 country
- Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant StudyActive, not recruitingNCT055325401 country
- Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or AboveActive, not recruitingNCT07285278Phase 21 country
- Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or AboveActive, not recruitingNCT07285265Phase 11 country
- A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy AdultsTerminatedNCT05703607Phase 1/21 country
- iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and NeuroblastomaActive, not recruitingNCT01953900Phase 11 country
- A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy ParticipantsCompletedNCT06375512Phase 12 countries
- A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and OlderActive, not recruitingNCT07311148Phase 21 country
- Seroprevalence and Vaccination Rate of Hepatitis B Virus and Varicella-zoster Virus Among Medical Students Under Immunizing ProgramCompletedNCT069013621 country
- Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and OlderActive, not recruitingNCT05304351Phase 21 country
- A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of AgeCompletedNCT05630846Phase 25 countries
- Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 YearsActive, not recruitingNCT06409494Phase 11 country
- Study on Booster Immunization With Varicella Vaccine at Different IntervalsCompletedNCT06994052Phase 41 country
- Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)CompletedNCT06987942Phase 41 country
- A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of AgeCompletedNCT05084508Phase 26 countries
- Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the PhilippinesCompletedNCT06314724Phase 31 country
- Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 YearsCompletedNCT06614816Phase 31 country
- A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 YearsCompletedNCT06592456Phase 31 country
- Systems Biology of Zoster VaccineCompletedNCT04047979Phase 21 country
- PREPARE-iVAC TrialCompletedNCT05924685Phase 41 country
- Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years OldCompletedNCT05158777Phase 31 country
- Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years OldCompletedNCT04384016Phase 41 country
- A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of AgeActive, not recruitingNCT05839301Phase 31 country
- A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella VaccineActive, not recruitingNCT05669625Phase 31 country